Navigation Links
Hypermarcas Commences Tender Offer To Purchase Up To U.S.$300 Million Of Outstanding U.S.$750 Million 6.500% Senior Notes Due 2021
Date:10/28/2013

SAO PAULO, Oct. 28, 2013 /PRNewswire/ -- Hypermarcas S.A. ("Hypermarcas") today announced the commencement of a cash tender offer (the "Tender Offer") to purchase up to an aggregate amount of U.S.$300 million (such amount, as the same may be increased in the sole discretion of Hypermarcas, the "Maximum Tender Amount") of its U.S.$750 million 6.500% Senior Notes due 2021 (the "Notes"). The terms and conditions of the Tender Offer are described in Hypermarcas' Offer to Purchase (the "Offer to Purchase") and the related Letter of Transmittal, each dated today.

Subject to the Maximum Tender Amount and the other terms and conditions described in the Offer to Purchase and the Letter of Transmittal, the Tender Offer will expire, unless earlier terminated by Hypermarcas in its sole discretion, at Midnight, New York City time, on November 25, 2013, unless extended by Hypermarcas (such time and date, as the same may be extended, the "Expiration Date"). Holders of the Notes who validly tender their Notes at or prior to 5:00 p.m., New York City time, on November 8, 2013, unless extended by Hypermarcas (such time and date, as the same may be extended, the "Early Tender Date") and do not validly withdraw such Notes, will be eligible to receive the Total Consideration (as defined below), which includes the Early Participation Payment (as defined below).  In addition to the consideration, accrued and unpaid interest on the purchased Notes will be paid from the last interest payment date to, but not including, the settlement date for such purchased Notes. The settlement dates for the Tender Offer will follow three business days after the Early Tender Date and Expiration Date, respectively. 

The "Total Consideration" for each U.S.$1,000 principal amount of the Notes validly tendered at or prior to the Early Tender Date and accepted for purchase pursuant to the Tender Offer w
'/>"/>

SOURCE Hypermarcas S.A.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GW Pharmaceuticals Commences Phase 1 Clinical Trial of GWP42006 as a Potential Treatment for Epilepsy
2. Perrigo Commences Launch Of Clobetasol Emulsion Propionate Foam, 0.05%
3. Vasomedical Common Stock Commences Trading on the OTCBB
4. Medbox, Inc. Commences Pursuit of Strategic Acquisitions
5. The Nairobi Hospital in Kenya Commences Treating Cancer with Advanced Radiotherapy Delivery Using Varian Equipment and Software
6. Actinium Pharmaceuticals Commences Screening for the Second Cohort of Patients in the Companys Ongoing Phase I/II Trial in Acute Myeloid Leukemia
7. Ocular Therapeutix Commences Pilot Phase II Travoprost Punctum Plug Study for the Treatment of Glaucoma
8. Perrigo Receives FDA Approval And Commences Launch Of Clobetasol Propionate Shampoo, 0.05%
9. American Pacific Corporation Commences Debt Refinancing
10. Bausch + Lomb Commences Tender Offer of Its 9 7/8% Senior Notes due 2015 (CUSIP Nos. 071707AN3 and U07190AA6)
11. Inaugural National Mobility Awareness Month Commences in May Saluting the More than 18 Million with Disabilities
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/17/2014)... 2014 STAAR Surgical Company (NASDAQ: ... implantable lenses and delivery systems for the eye, today ... 2014 Medical Technology & Diagnostics Forum in ... on Thursday, November 20 at 12:30 p.m. PT/3:30 p.m. ... overview of the Company,s current business trends, financial results, ...
(Date:11/17/2014)... Calif. , Nov. 17, 2014 Asterias ... in the emerging field of regenerative medicine, today announced ... of Research and Development, will participate in a live ... Regenerative Medicine (CIRM) discussing the latest progress in stem ... The CIRM Google Hangout session is scheduled for Tuesday, ...
(Date:11/17/2014)... 17, 2014  CTI BioPharma Corp. (CTI) (NASDAQ and MTA: ... investor conferences. Jefferies 2014 Global Healthcare Conference ... EST, London, England . ... December 3 at 9:00 a.m. EST, New York, ... webcast live and available for replay after the presentation. The webcast ...
Breaking Medicine Technology:STAAR Surgical To Present At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum 2Asterias Biotherapeutics to Participate in Live Google Hangout Discussion of Stem Cell-Based Therapies for Spinal Cord Injury 2CTI BioPharma to Present at the Upcoming Investor Conferences 2
... Edge EHR Corp., EDGE, a provider of Dental ... to announce the release of edgeDMS™ for ... leverage the awesome power of the Apple® iPad. ... (Logo:   http://photos.prnewswire.com/prnh/20100310/AQ68604LOGO ) The ...
... Calif., Dec. 21, 2010 Jazz Pharmaceuticals, Inc. (Nasdaq: ... States Patent and Trademark Office (USPTO) has issued a ... "Microbiologically Sound and Stable Solutions of Gamma-Hydroxybutyrate Salt for ... is also listed in the FDA,s Approved Drug Products ...
Cached Medicine Technology:Edge EHR Corp. Announces edgeDMS for iPad, Native Touch-Based Clinical Charting Software for the Paperless Dental Office. 2Jazz Pharmaceuticals Announces New Patent Issued for Sodium Oxybate 2
(Date:11/18/2014)... Cristcot Inc., a global life sciences ... specialized drug delivery systems, today announced that the ... for the technology, which encompasses the company’s commercially ... patent was awarded to the inventor Jennifer Davagian ... to Cristcot Inc. The patented technology, titled “Method ...
(Date:11/18/2014)... Medicationdiscountcard.com's blog offers health ... company's reputation for helping consumers save money at ... offer at http://blog.medicationdiscountcard.com/ . , Consumers need ... Affordable Care Act and the state health benefit ... about a variety of prescription drug and health ...
(Date:11/18/2014)... HealthDay Reporter MONDAY, Nov. 17, ... prove effective at lowering LDL ("bad") cholesterol levels for ... That,s the conclusion of a clinical trial presented ... Chicago. The drug, alirocumab, outperformed the on-the-market medication ... statins, Zetia, said lead researcher Dr. Patrick Moriarty, director ...
(Date:11/18/2014)... 2014 (HealthDay News) -- Women who started smoking at ... chronic, severe menstrual pain, a new study suggests. ... While smoking has been suspected as a risk factor ... the authors of the new study said. The ... a long-term study of women,s health in Australia. About ...
(Date:11/18/2014)... 18, 2014 Global Partnership ... the telehealth platform to bring quality healthcare to ... passion, GPT created Global Partnership for TeleHealth Missions ... existing telehealth network. GPTM focuses specifically on ... and disaster relief organizations. , Michael ...
Breaking Medicine News(10 mins):Health News:Japanese Patent Office Grants Patent to Cristcot Inc. 2Health News:Medicationdiscountcard.com Building Virtual Library of Resources to Help Consumers Navigate Healthcare Landscape 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 2Health News:Experimental Cholesterol-Lowering Drug Effective, Study Reports 3Health News:Study Ties Teen Smoking to Risk of Severe Menstrual Cramps 2Health News:Global Partnership for TeleHealth (GPT) is Focused on Using the telehealth Platform to Bring Quality Healthcare to Populations in Need Worldwide 2
... a History of Eating Disorders More at Risk for ... for Eating and Anxiety Disorders ( www.remudaranch.com ), the ... new pressure to look perfect while pregnant. "With the ... an increased pressure to look perfect and thin during ...
... is the only authorized online learning program ... Known for bringing innovation to the chiropractic ... only web-based seminar program dedicated exclusively to ... Online, the online learning system authorized by ...
... 19 Abbott announced today,that the U.S. ... the Clinical Laboratory Improvement Amendments of 1988 (CLIA) for ... analyzer. , Cartridges for E3+, ... patient,s,metabolic state within a few minutes. The glucose ...
... Amazing Heat Pack by Comfort Now, Inc., a revolutionary ... pain relief for athletes, arthritics, chronic pain sufferers, premenstrual ... musclesBURLINGTON, Ontario, Jan. 19 Not since the 1920 ... aid product been released as The Amazing Heat Pack, ...
... Commitment to Healthy and Successful Vascular Access for ... Vascular Access(SM), the nation,s leading provider of vascular ... of managed vascular access centers has collectively ,touched, ... Lifeline Vascular Access managed center Nephrology Vascular Lab ...
... The 2008 Frost & Sullivan Technology Innovation Award ... presented to TECNIMED srl for pioneering THERMOFOCUS, the first ... available with a new, rapid, room temperature stabilization system. ... the company that has demonstrated technological superiority within its ...
Cached Medicine News:Health News:Remuda Ranch Reports More Women Seek to Be Thin During Pregnancy 2Health News:Activator Methods Introduces Web-Based Seminar Program 2Health News:Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer 2Health News:Abbott Receives FDA CLIA Waiver for Use of Five Additional Cartridges on the i-STAT Handheld Blood Analyzer 3Health News:The Amazing Heat Pack: The Most Innovative First Aid Solution Since the Band-Aid 2Health News:Lifeline Vascular Access Treats a Quarter Million Patients 2Health News:Lifeline Vascular Access Treats a Quarter Million Patients 3Health News:TECNIMED Picks Up Frost & Sullivan Award for its Innovative THERMOFOCUS 2Health News:TECNIMED Picks Up Frost & Sullivan Award for its Innovative THERMOFOCUS 3Health News:TECNIMED Picks Up Frost & Sullivan Award for its Innovative THERMOFOCUS 4
... The Vitros 250 is ... meet requirements in multiple environments ... large hospitals, clinics and satellite ... features on-board dilution, and can ...
The IMx system is an automated analyzer designed to perform microparticle enzyme immunoassay (MEIA), fluorescence polarization immunoassay (FPIA) and ion capture technologies....
Architect i2000 is a flexible solution for your evolving laboratory providing high throughput and walkaway time with built-in flexibility....
... The Bayer Immuno 1 provides ... immunoassay instrument with over 50 ... endocrinology, tumor marker, therapeutic drug, ... can be performed on a ...
Medicine Products: